Revamped fine needle aspiration biopsy measures may boost safety, cut costs for older patients

Recent research published in Current Problems in Diagnostic Radiology suggests new strategies in thyroid fine needle aspiration (FNA) to avoid biopsies may be safer and more cost effective in older patients.

In the study, published online March 2, researchers noted thyroid nodules are present in 50 to 60 percent of the population and “biopsy of thyroid nodules in the veteran population is common, and in our experience, these nodules are almost always benign,” wrote Sean D. Raj, MD, with the department of radiology at Baylor University Medical Center and American Radiology Associates in Dallas, and colleagues.

The team conducted a retrospective study of 351 successive all ultrasound-guided FNA of thyroid nodules. The average patient age was 65.7, and 81 percent of participants were male.

Radiologists used the Society of Radiologists in Ultrasound (SRU) Consensus Statement in 2005 to review sonographic patterns and implement a positive predictive value (PPV) of malignancy.

Four sonographic patterns were 100 percent specific for benignity, including “spongiform,” “cyst with a colloid clot,” “giraffe” and “white knight” patterns.

Researchers then implemented a prospective avoidance of 125 FNA lesions marked as a benign pattern over 23 months—nine were malignant, resulting in PPV of 7.2 percent and cost savings of $477,000.

“Implementation of these strategies in this patient population, specifically avoiding biopsy of lesions with sonographic patterns of benignity, is adaptable to other practice settings while improving patient care and optimizing allocation of clinical resources,” wrote Raj et al. “This approach and simple modification to thyroid nodule evaluation will improve diagnostic efficiency and result in a marked decrease in patient morbidity, emotional and physical burdens associated with FNA, and minimize healthcare costs.”

""

Matt joined Chicago’s TriMed team in 2018 covering all areas of health imaging after two years reporting on the hospital field. He holds a bachelor’s in English from UIC, and enjoys a good cup of coffee and an interesting documentary.

Around the web

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.